Therapeutics company Algeta ASA has applied for listing on the Oslo Stock Exchange. The company raised NOK 185m in series-A financing from a consortium of investors, including HealthCap, Advent Venture Partners, SR One, and existing investors, Selvaag Venture Capital, NorgesInvestor, Marlin Verdi AS and several smaller investors in 2005. .
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater